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ABSTRACT
Currently, fetal bovine serum (FBS) have been widely use in culture media to promote human cell proliferation. However, 
the usage of FBS for cell therapy in clinical application was associated with the risk of viral and prion transmission as 
well as immune rejection. To provide an option for this risk, this study was conducted to determine the effect of  adipose 
derived stem cells (ADSCs) co-culture with chondrocyte in promoting cell proliferation and chondrogenesis toward 
FBS free condition. ADSCs co-cultured with chondrocyte at the ratio of 1:1, 2:1 and 1:2 were tested. Cell morphology 
changes, cell proliferation and gene expression level of stemness (Oct4, FGF-4, Nanog) and chondrogenic (Collagen 
Type II, ACP) were assessed. The results showed ADSCs in all co-culture groups changed morphology from fibroblastic 
spindle to polygonal shape which resembled chondrocytes. The morphological changes were accompanied with increased 
expression of chondrogenic genes; denoted chondrogenesis process. While maintaining expression of stemness genes 
indicated continuation of cell proliferation. From the three co-culture groups tested; ADSCs and chondrocytes (1:1 ratio) 
have been shown to exert better effects in promoting cell proliferation and chondrogenesis. In conclusion, ADSCs could 
replace FBS to grow sufficient number of chondrogenic cells to repair cartilage injury in the near future. Further in vivo 
study should be performed to test the effectiveness of this co-culture technique in cartilage injury repair. 
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ABSTRAK
Pada masa kini, serum fetus bovin (FBS) telah digunakan secara meluas di dalam media kultur sebagai faktor penggalak 
pertumbuhan sel. Namun begitu, penggunaan FBS untuk terapi sel secara klinikal dikaitkan dengan risiko transmisi virus 
dan prion serta tolakan imun. Bagi menangani risiko ini, kajian ini dijalankan bagi menentukan kesan ko-kultur sel stem 
adipos (ADSCs) dan kondrosit terhadap proliferasi sel dan kondrogenesis kearah kondisi pengkulturan bebas FBS. ADSCs 
dikultur bersama kondrosit dengan nisbah 1:1, 1:2 dan 2:1 telah diuji. Perubahan morfologi sel, proliferasi sel dan 
ekspresi gen kesteman (Oct4, FGF-4, Nanog) dan gen kondrogenik (kolagen jenis II dan ACP) telah dinilai. Keputusan 
kajian mendapati ADSCs dalam semua kumpulan ko-kultur berubah morfologi daripada bentuk fibroblas memanjang 
kepada bentuk poligon yang menyerupai kondrosit. Perubahan bentuk ini turut disertai dengan ekpresi gen kondrogenik 
yang meningkat, ini menandakan proses kondrogenesis telah berlaku. Sementara itu, ekspresi gen kesteman memberi 
penunjuk bahawa proliferasi sel dapat diteruskan. Daripada tiga kumpulan kajian nisbah ko-kultur yang dikaji; ADSCs 
bersama kondrosit (1:1 ratio) telah menunjukkan kesan yang lebih ketara dalam menggalakkan proliferasi sel dan 
kondrogenesis. Kesimpulannya, ADSCs berpotensi menggantikan FBS sebagai faktor pertumbuhan bagi menyediakan 
jumlah kondrosit yang mencukupi untuk merawat kecederaan rawan pada masa hadapan. Kajian seterusnya di dalam 
model in vivo perlu dijalankan bagi menguji keberkesanan teknik ko-kultur ini bagi merawat kecederaan rawan. 
Kata kunci: Kondrosit; penggunaan klinikal; rawan; sel asal; serum
INTRODUCTION
Serum has been widely used as supplement in cell culture 
media and it is essential for cell attachment, growth, 
metabolism and acts as a buffering agent to maintain 
the pH of cell culture media. The most commonly used 
serum to support cell growth is derived from animals, 
mainly from bovine fetus. Fetal bovine serum (FBS) 
contains components such as proteins, growth factors, 
trace elements and hormones that are necessary for cell 
proliferation and maintenance of cells physiology (Valk et 
al. 2010). Despite the known advantages of serum in cell 
culturing media, there are a few drawbacks associated with 
the use of serum especially from animal sources. First of 
all, increased utilisation of fetal bovine serum for routine 
cell culture works worldwide demands more bovine fetuses 
to be sacrificed and the collection of serum may cause 
suffering for the unborn calf (Brunner et al. 2010; Valk 
et al. 2004). Secondly, fetal bovine serum may also be 
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the possible source of xenogeneic contaminations in cell 
culture such as contamination of virus and prion. In fact, 
20 to 50% of commercial FBS was reported related to virus 
contamination (Wessman & Levings 1999).  In addition, 
bovine protein could also attach to cells in culture and 
acts as antigenic substances that induce immunological 
reactions during transplantation (Ferdinando & Gaetana 
2007). Thirdly, there are batch to batch variations that 
compromised the quality of the serum hence testing is 
necessary to maintain the quality of each batch for cell 
culture. As a result, phenotypical differences might occur 
in the cell culture leading to inconsistency of the data or 
the final products (Valk et al. 2010). These limitations 
hinder the clinical application of cells that is cultured in 
media contain serum and signify the demand of safer and 
more reliable method to replace the serum. The potential 
replacement of FBS by stem cells will be discussed in 
this study. 
 Stem cells, widely known for their self-renewal 
and wide differentiation potentials represent a viable 
alternative for tissue regeneration (Tapp et al. 2009). 
The discovery of stem cells residing in human adipose 
tissue has drawn attention to the tissue engineering field 
and offers novel tools to treat various diseases, such 
as autoimmune-induced diseases (Gonzalez-Rey et al. 
2010), multiple sclerosis (Riordan et al. 2009), treatment 
of fistulas in Crohn’s disease (García-Olmo et al. 2005) 
and potential for microtia repair (Goh et al. 2017). The 
initial method to isolate cells from adipose tissue were 
introduced by Rodbell et al. (1960) and the isolation 
yielded two populations of cells, the floating mature 
adipocytes and stromal vascular fractions (SVF). The 
stromal vascular fraction includes heterogeneous cell 
population, including preadipocytes, fibroblasts, smooth 
muscle cells, lymphocytes, macrophages, endothelial 
cells and adipose derived stem cells (ADSCs). The 
ADSCs that are isolated from adipose tissue possess high 
proliferative capability (Zuk et al. 2002) and can undergo 
various differentiation pathways, including osteogenic 
(Grottkau & Lin, 2013), adipogenic (Turner et al. 2017), 
chondrogenic (Hamid et al. 2012), neurogenic (Zhao 
et al. 2015), smooth muscle (Salah et al. 2013) and 
insulin-producing cells (Mohamad Buang et al. 2012). In 
addition, ADSCs have been shown to enhance the recovery 
of injured human hepatocellular carcinoma (HepG2) 
through secretion of Hepatocyte Growth Factor (HGF) and 
Vascular Endothelial Growth Factor (VEGF) (Liau et al. 
2018). As one of the most promising stem cells population 
identified, ADSCs offers two main advantages over other 
types of stem cells such as bone marrow stem cell and 
embryonic stem cells. Firstly, ADSCs can be harvested in 
large quantities with little donor site morbidity during 
subcutaneous liposuction procedure. Secondly, ADSCs 
eliminate ethical concerns associated with the usage of 
embryonic stem cells because they can be derived from 
autologous fat (Cawthorn et al. 2012). 
 In the light of increasing aging population worldwide, 
people are more susceptible to the musculoskeletal 
disorders such as osteoarthritis (OA), rheumatoid arthritis 
(RA), low back pain (LBP) and neck pain (NP) (Woolf 
2015). Osteoarthritis, the most common form of arthritis, 
involves inflammation and major structural changes of 
the joint which causes pain and functional disability 
(Cross et al. 2014). As a result, enormous costs for 
health and social care systems are involved in managing 
osteoarthritis patients. In Asia, it has been estimated that 
the percentage of people aged 65 years will increase 
from 6.8% in 2008 to 16.2% in 2040 (Fransen et al. 
2011). Since OA has a strong relationship with ageing, the 
above-mentioned figure is of concern as it is indirectly 
reflected the impairment of life quality among the elderly 
affected with osteoarthritis. Furthermore, the recovery 
of cartilage lesion in osteoarthritis remains challenging 
because cartilage tissue has a very limited capacity for 
intrinsic healing. This is due to poor vascularisation, low 
chondrocyte density and poor mobility of chondrocytes 
(Wang et al. 2017). 
 Autologous chondrocytes implantation (ACI) is a 
procedure that has shown promising outcomes for articular 
cartilage regeneration in early clinical studies (Breinan 
et al. 1997; Nehrer & Minas 2000). For ACI, autologous 
chondrocytes are harvested arthroscopically from non-
weight-bearing area of the articular cartilage and grown 
in monolayer cell culture to larger numbers in vitro. Once 
sufficient numbers are reached, cultured chondrocytes 
suspension is injected into the articular defect which is 
then covered by a periostal flap or collagen membrane 
(Afizah et al. 2007). The effectiveness of ACI have been 
shown previously by a long-term study of Brittberg et al. 
(1994) and Brittberg (1999) and this procedure can be 
modified with incorporation of biodegradable material 
with autologous chondrocytes in vitro before being 
implanted to the patients. Despite the clinical effectiveness 
of ACI, the procedure has been associated with significant 
donor-site morbidity, a slow rate of chondrocyte 
proliferation (Nejadnik et al. 2010) and difficulty in 
obtaining an adequate number of chondrocytes. To 
achieve a sufficient number of chondrocytes for ACI, 
the cells need to be expanded in a monolayer condition. 
However, chondrocytes that are released from the cartilage 
matrix and placed in monolayer culture dedifferentiate 
to fibroblast-like state and have a tendency to lose their 
chondrocyte-specific phenotypes (Benya & Shaffer 1982; 
Domm et al. 2002; Schnabel et al. 2002). Dedifferentiation 
of chondrocyte in monolayer culture is accompanied by 
morphological changes and collagen expression profiles 
(Fuss et al. 2000; Stewart et al. 2000) and can occur as 
early as in the first passage (Schulze-Tanzil et al. 2002). 
This occurrence may limit the chondrocyte expansion and 
proliferation in an attempt to treat big lesions through ACI 
procedure. 
 Previous studies have proven that co-culture technique 
may provide environment that is necessary for stem cell 
differentiation and promote chondrocyte proliferation. 
The studies have primarily utilised bone marrow derived 
stem cells and to a lesser extent, adipose-derived stem 
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cell (Waters et al. 2013). In most cases, 10% FBS along 
with growth factors including transforming growth factor 
(TGF) β1 and β3, basic fibroblast growth factor (bFGF), 
bone morphogenic protein-6 (BMP-6), dexamethasone were 
supplemented in the growth media during cell culturing to 
enhance chondrogenic differentiation (Bahney et al. 2011; 
Waters et al. 2013). However, little is known about the 
potential of ADSCs in co-culture environment to replace FBS 
as a source of growth factors to promote cell proliferation 
of chondrocyte in vitro. 
 In the present study, chondrocytes and adipose derived 
stem cells (ADSCs) with 1:1, 1:2 and 2:1 ratio were co-
cultured in order to evaluate if ADSCs could replace FBS 
as growth factor in culturing medium. The aim of this 
study was to answer the following research questions: 
Can ADSCs replace FBS as commonly used growth factors 
and lead to increase proliferation of chondrocytes in co-
culture system? Do different co-cultures ratio of ADSCs and 
chondrocyte influence cell proliferation and chondrogenic 
markers expression? The outcome of this study should 
provide a better understanding of the effect of ADSCs in 
chondrogenic co-culture system in minimal effect of FBS 
as a strategy to improve proliferation of chondrocytes in 
vitro towards clinical application.
MATERIALS AND METHODS
ETHICS STATEMENT
Abdominal subcutaneous tissue was collected from 
consented patient undergoing caesarean section in the 
Department of Obstetrics and Gynaecology, Universiti 
Kebangsaan Malaysia Medical Centre. Cartilage was 
collected from patients undergoing nasal septoplasty 
procedure in the Department of Otorhinolaryngology, 
Universiti Kebangsaan Malaysia Medical Center. Sample 
collection and research protocols were reviewed and 
approved by the Universiti Kebangsaan Malaysia Medical 
Research and Ethics committee (FF-068-2013). 
ISOLATION OF ADIPOSE DERIVED STEM                                
CELLS (ADSCS) ISOLATION
Adipose tissue was collected in a sterile container and 
processed for stem cell isolation within 30 min of sample 
collection. Tissues were washed three times with 
phosphate-buffered saline (PBS; pH7.2; Invitrogen, Grand 
Island, USA) and minced into smaller pieces. The tissue 
was digested in 0.3% collagenase type I (Worthington, 
Lakewood, NJ) and placed in orbital shaker at 37oC with 
continuous agitation. After centrifugation, the supernatant 
containing mature adipocytes, was discarded and the 
cell pellet was suspended in culture medium (Ham’s 
F12: Dulbecco’s Modified Eagle Medium (F12: DMEM) 
supplemented with 10% FBS (Invitrogen), 1% Vitamin 
C (Sigma, St. Louis, MO) 1% antibiotic-antimycotic 
(Invitrogen), 1% Glutamax (Invitrogen) and plated 
immediately in T25 flasks. This initial passage of the 
primary cell culture was referred to as passage 0 (P0). 
Cultures were maintained in an incubator with 5% CO2 
at 37°C. Cells were passaged repeatedly after achieving 
a density of 75%-90% (approximately 4 days in culture) 
until passage 4.
FLOW CYTOMETRY ANALYSIS
For ADSCs characterisation, cell surface antigen 
phenotyping was performed on ADSCs at passage 4. The 
cells were incubated with anti-human antibodies: CD9-
phycoerythrin (PE), CD34-fluorescein isothiocyanate (FITC), 
CD117-PE, CD31-PE, CD44-FITC, CD-45-FITC, CD73-FITC, 
CD90-FITC, HLA ABC-FITC and HLA DP-DQ-DR-FITC (BD 
Biosciences, NJ, USA). Approximately 10,000 labeled cells 
were acquired for each surface marker and the data were 
analyzed using CELLQuestPro acquisition software (BD 
Bioscience, Franklin Lakes, NJ, USA). 
ISOLATION OF CHONDROCYTES
The collected cartilage was cleaned by removing the 
adhering soft connective tissue and bone segment using 
phosphate buffer saline (PBS). Then, the cartilage was 
minced into smaller pieces and placed in 0.6% Collagenase 
Type II buffer for 3-4 h in a 37oC shaker incubator. 
Subsequently, the cell pellet was harvested after repeated 
centrifugation and rinsed with PBS. Finally, the pellet was 
suspended in Ham’s F12: Dulbecco’s Modified Eagle 
Medium (F12:DMEM) supplemented with 10% FBS and 2 
μL of Insulin Transferrin Selenium (ITS) and transferred 
into a 6-well plate. The culture was maintained in a 
humidified incubator with 5% CO2 at 37°C. After reaching 
90% confluence, the primary culture (P0) was trypsinised 
using 0.125% trypsin-EDTA and passaged at a culture 
expansion ratio of 1:3 until passage 1 (P1).
CELL LABELLING
To observe the morphological features of the cells, 
chondrocytes and adipose derived stem cells were 
detached using 0.125% Tripsin EDTA and 1.5 uL of 10 
mM CellTracker™ (Invitrogen) dye, CellTracker™ 
Green CMFDA (5-chloromethylfluorescein diacetate) for 
chondrocytes and CellTracker™ Red CMTPX for hADSCs 
were added.
CO-CULTURE OF ADSCS WITH CHONDROCYTES
ADSCs and chondrocytes were seeded onto a 24-well plate 
at a respective ratio (Table 1) to yield 9 × 104 cells/well 
and cultured with Ham’s F12: DMEM media supplemented 
with 1% FBS. 
TOTAL CELL NUMBER DETERMINATION
To determine total cell number all co-cultures group were 
trypsinised using 0.125% Trypsin EDTA and the cell number 
were determined using haemacytometer and Trypan Blue 
dye exclusion. 
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QUANTITATIVE GENE EXPRESSION ANALYSIS BY REAL-
TIME POLYMERASE CHAIN REACTION (qPCR)
To determine the mRNA expression of chondrogenic and 
stem cell associated markers, the cDNA was subjected 
to quantitative PCR analysis using IQTMSYBR®Green 
Supermix (Bio-Rad, Hercules,CA). The sets of primer 
used to study the gene of interest were Collagen Type II 
(Col II), Aggrecan Core Protein (ACP), Nanog homeobox 
pseudogene 3 (Nanog3), Octamer Binding Protein 
(Oct-4) and Fibroblast Growth Factor (FGF-4) (Table 1). 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH was 
used as the housekeeping gene to normalise the data. The 
specific primers were designed using Primer 3 software 
according to published GeneBank database sequences. 
The quantitative PCR reaction was performed using SYBR 
Green as a dye to detect PCR products in BioRad iCycler 
PCR machine. The reaction mixture consisted of iQ SYBR 
Supermix, forward and reverse primers (500 nM each), 
deionised water and the respected cDNA. The reactions 
were performed under following conditions:
 Cycle 1: Step 1 95°C  for 3 min (1 time), cycle 2: Step 
1 95°C  for 10 s and Step 2 61oC for 30 s (40 times), cycle 
3: Step 1 95°C  for 1 min (1 time), cycle 4: Step 1 55°C 
for 1 min (1 time) and cycle 5: Step 1 60°C  for10 s (70 
times). To verify the specificity of each PCR product, gel 
electrophoresis analysis was performed. Each PCR products 
was subjected to 2% agarose (Invitrogen, Carlsbad, CA, 
USA) gel electrophoresis stained with ethidium bromide 
(Sigma-Aldrich, St. Louis, MO, USA) and visualised using 
UV transillumination (Vilber Lourmat, Marne La Vallee, 
France).
STATISTICAL ANALYSIS
Data were analysed using SPSS 15.0 (SPSS Inc. Chicago, IL, 
USA) and presented as mean + standard error of mean (SEM) 
and standard deviation (SD). One-way ANOVA statistical 
analysis was performed using GraphPad Prism version 7 
(La Jolla California USA) and a difference at the 5% level 
was considered as a statistically significance. 
TABLE 2. List of primers used in quantitative polymerase reaction chain (qPCR)
Gene Acession no. Primer sequences (5’…..3’) Product size (bp)
GAPDH NM_002046 F: tcc ctg agc tga acg gga ag
R: gga gga gtg ggt gtc gct gt
217
COL II NM_001844 F: cta tct gga cga agc agc tgg ca
R: atg ggt gca atg tca atg atg g
209
ACP NM_001135 F:cac tgt tac cgc cac ttc cc
R: acc agc gga agt ccc ctt cg
118
NANOG NM_024865.2 F: ctg tga ttt gtg ggc ctg aa
R: tgt ttg cct ttg gga ctg gt
153
FGF-4 NM_002007 F: gat gag tgc acg ttc aag ga
R: ggt tcc cct tct tgg tct tc 
118
OCT-4 NM_002701 F: 5’-aag gat gtg gtc cga gtg tg-3’
R: 5’-gaa gtg agg gct ccc ata gc-3
180
TABLE 1. Mixture ratio of ADSCs and chondrocyte
ADSCs Chondrocytes
Control 9 × 104 -
1:2 3 × 104 6 × 104
1:1 4.5 × 104 4.5 × 104
2:1 6 × 104 3 × 104
Control - 9 × 104
RNA EXTRACTION 
Total RNA was extracted from all co-culture groups at day 
5 using TRI-Reagent (Molecular Research Centre, USA) in 
accordance with manufacturer’s instruction. About five 
mL of polyacryl carrier (Molecular Research Centre, USA) 
was added to precipitate the total RNA. The RNA pellet was 
washed with 75% ethanol and dried before dissolving 
in DNase- and RNase- free distilled water (Invitrogen). 
The total RNA yield and integrity was determined by 
spectrophotometer (Bio-Rad, USA). The extracted RNA was 
immediately stored at -80oC until further analysis.
CDNA SYNTHESIS
Approximately 5 μL of total RNA from co-culture cells 
was used to synthesise cDNA using Superscript_ III First-
Strand Synthesis kit (Invitrogen) which contained reverse 
transcriptase enzyme mix, 2_ RT reaction mix and E. 
coli RNase H. The reaction was conducted according to 
instruction from the manufacturer. The protocol conditions 
used were 10 min at 23°C, 60 min at 42°C, and 10 min 
at 94°C. The synthesised cDNA was used as a template to 
perform qPCR to assess the expression level of the stemness 
genes (Oct-4, FGF-4, Nanog) and chondrogenic genes 
(Collagen Type II and ACP).
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RESULTS AND DISCUSSION
Normal growth media often contain 2-10% of serum for 
growth and maintenance of cells. Although FBS has been 
widely used as growth supplementation to promote cell 
proliferation, the use of FBS is controversial for a number 
of reasons particularly with regards to safety and efficacy 
of cells that are cultured in the presence of FBS. Hence, in 
this study we reported the feasibility of ADSCs to replace 
serum in co-culture model to enhance cell proliferation 
of chondrocytes in vitro. Although 10% of FBS was used 
at the initial stage of ADSCs culture, the FBS concentration 
were reduced to 1% for cell attachment in the culture 
media used during co-culture. For a clinical application, 
the 10% FBS for initial cultivation of ADSCs are easily 
replaceable with the currently available serum free culture 
media. While, the low FBS concentration (1%) used during 
co-culture of ADSCs and chondrocyte can be replaced with 
1% autologous human serum for autologous application. 
Human serum is a better alternative for cell culture because 
it is economical, safer and easily available. Human serum 
has been shown to promote ADSCs proliferation (Hui et al. 
2012), bone marrow derived stem cell growth (Shahdadfar 
et al. 2005) and promote engraftment after allogenic 
transplantation of human peripheral blood haematopoetic 
stem cells in NOD/SCID mice (Kim et al. 2005). In our 
study, ADSCs is characterised by flow cytometry analysis. 
ADSCs displayed positive staining for stromal associated 
markers (CD90- 99.9%, CD73-99.7%, CD44-99.4%), stem 
cell adhesion molecule (CD9-91.2%) and MHC class I (HLA 
ABC-91.2%). On the contrary, ADSCs lacking expression 
of haematopoietic markers (CD31-1.9%, CD45-6.3%), stem 
cell factor (CD117-2.4%) and histocompatibility antigen 
class II (HLA DP-DQ-DR-3.0%). 
EFFECTS OF CO-CULTURE OF ADSCS WITH          
CHONDROCYTES ON CELL PROLIFERATION
The results from our study indicated that, the co-culture of 
chondrocytes with ADSCs promoted cell proliferation in all 
co-culture ratio groups as compared to the chondrocytes 
alone. On day 5 of culture, the cell numbers were 
significantly higher in all ADSCs and chondrocyte co-culture 
groups as compared to ADSCs and chondrocytes alone. The 
cells showed highest proliferation in co-culture group of 
1:1 and 1:2. While the co-culture group showed the least 
cell proliferation was in group of 2:1. Statistical analysis 
showed significant difference of cell proliferation between 
the co-culture groups of 1:1, 1:2 and 2:1 when compared 
with control groups (chondrocytes and ADSCs) (p<0.05). 
However, there was no significant difference in the cell 
proliferation between all co-culture groups (Figure 2). 
The effects might be due to soluble factors, VEGF, HIF-1α, 
IGF-1 and fibroblast growth factor that were secreted by 
ADSC as confirmed by a previous study (Zhong et al. 2016). 
Using co-culture model, Kim et al. (2007) reported that 
ADSCs promoted human dermal fibroblast proliferation 
by cell-to cell contact as well as paracrine activation. One 
dimensional gel electrophoresis combined with tandem 
mass spectrometry analysis showed that ADSCs secreted 
growth factors, collagen and fibronectin that are important 
for cell growth and proliferation (De Lany et al. 2005; 
Kratchmarova et al. 2002). Findings from these studies 
were in consistent with the term ‘trophic’ that has been 
introduced by Caplan and Dennis (2006) in describing the 
factors secreted by mesenchymal stem cells. This term is 
also associated with the effect of the factors produced by 
mesenchymal cells in supporting in the proliferation and 
matrix production of neighbouring cells. 
EFFECT OF CO-CULTURE OF ADSCS WITH CHONDROCYTE 
ON CHONDROGENESIS AND STEMNESS GENE EXPRESSION
Despite the suggested trophic effect of ADSCs that helps in 
cell proliferation, we did not exclude the possible influence 
of chondrocytes in promoting ADSCs differentiation. 
In the presence of chondrocytes, ADSCs are directed 
into chondrogenic differentiation demonstrated by 
the morphological changes of ADSCs from the initial 
fibroblastic like cells to polygonal like cells that resemble 
chondrocytes. Cell morphology of control (ADSCs and 
chondrocytes only) and co-culture groups were assessed 
FIGURE 1. Histogram showing the total cell number at day 5 of control (adipose derived stem and 
co-culture groups. Adipose derived stem cells (ADSCs) were cultured with chondrocytes in 1:1, 
1:2 and 2:1 ratio. Results showed as mean + SEM of three independent experiments. *p<0.05
D
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FIGURE 2. Cell morphology of adipose derived stem cells (ADSCs) were assessed under inverted and fluorescence 
microscope on day 1, 3 and 5. Morphology of ADSCs at day 1,3 and 5 under bright field (A-F) and cell tracker labelled 
ADSCs as indicated by red-stained cells (G-I). As early as day 1, the adherent ADSCs grew into spindle shaped cells and 
the cell phenotype remains up to day 5. The ADSCs reached 90% of confluence at 5th day of culture (A-C)
under inverted and fluorescence microscope on day 1, 3 
and 5 (Figures 2-5). In a monolayer culture, ADSCs exhibit 
fibroblastic-shape feature while chondrocytes exhibit 
polygonal-shaped throughout day 1, 3 and 5 of culture 
(Figures 2 & 3). In co-culture groups with a ratio of 1:1 
and 1:2, some of the ADSCs that were initially spindle 
shape (red-stained) have changed into polygonal shaped 
cells. These morphological changes can be particularly 
seen at day 3 and 5 in the co-culture group with a ratio of 
1:1 and 1:2 (Figure 5). The morphological changes were 
accompanied by expression of chondrogenic specific 
markers (Collagen Type II and ACP) in all co-culture 
groups. In order to assess the effect of co-culture ratios 
on mRNA expression level of chondrogenic markers, 
qPCR was performed on Collagen Type II and Aggrecan 
core protein (ACP). Cells cultured in a co-culture group 
expressed chondrogenic specific marker, Col II and ACP 
at day 5. Between all co-culture groups, group with a ratio 
of 1:1 showed higher expression of Collagen Type II while 
group with a ratio of 1:2 showed higher expression of ACP. 
However, there was no statistically difference of Collagen 
Type II and ACP expression between all co-culture groups 
(1:1, 1:2, 2:1) with control (chondrocytes) (Figure 6). 
Collagen Type II and aggrecan are specific markers for 
regenerated cartilage (Anderer & Libera 2002; Schulze-
tanzil 2009) and the expression of these markers are 
significant to differentiate between hyaline cartilage and 
fibrocartilage. Fibrocartilage may function satisfactorily 
in cartilage repair for a certain period of time, however it 
does not exhibit normal articular material property. As a 
result, the repair will be less durable to withstand loading 
than normal articular cartilage (Frenkel SR & Di Cesare 
1999). Our results indicated that chondrocytes may exert 
some effects in promoting chondrogenic differentiation 
of ADSCs. Previous studies done using mesenchymal stem 
cells showed similar results when mesenchymal stem cells 
were cultured together with chondrocytes (Yang et al. 2012; 
Xu et al. 2013). Interestingly, co-culture group cells also 
expressed stem cell associated markers, Oct-4, Nanog 
and FGF-4. In all co-culture groups, the expression of 
Oct-4, FGF-4, and Nanog were relatively low as compared 
to ADSCs alone (Figure 6). The expression of stem cell 
associated markers gave the implication that there was 
still stemness property exhibited by ADSCs although in a 
co-cultured environment that favours chondrogenesis. We 
believed with the extension of culturing period, there was 
a possibility that the remaining ADSCs in the co-culture 
could be differentiated into chondrogenic lineage. But 
the most important part that contributed to the success of 
the co-culture system is the ideal ratio of both cells. An 
ideal ratio should yield high quality cartilage as well as to 
minimize the usage of fetal bovine serum in cultures. In 
the present data, group ratio of 1:1 (ADSCs: chondrocytes) 
has greater effect on cell proliferation and chondrogenic 
gene expression as compared to other groups. Viable 
chondrocyte is very difficult to be obtained from the 
patient cartilage and if successful, only a small number of 
chondrocyte can be harvested. In the ratio of 1:1 (ADSCs: 
chondrocytes), less number of chondrocytes is needed to 
start the culture. Although a ratio of co-culture 1:2 showed 
almost similar outcome, there was possibility that the 
expression of high stemness marker as indicated in FGF-4 
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FIGURE 3. Morphology of chondrocytes from nasal septum cultured in vitro. Primary polygonal 
nasal septum chondrocytes were grown at day 1, 3 and 5 under bright field (A-F) and cell tracker 
labelled chondrocytes as indicated by green-stained cell (G-I)
FIGURE 4. Cell morphology of ADSCs co-cultured with chondrocyte cultured at the 
ratio of 1:1, 1:2 and 2:1 under bright field
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FIGURE 5. Morphological changes of cell tracker labelled of chondrocytes and adipose derived stem cells (ADSCs) with 1:1, 
1:2 and 2:1 ratio observed under fluorescence microscope at day 1, 3 and 5. Red: ADSCs, Green: chondrocyte
FIGURE 6. Histogram showing mRNA relative gene expression of chondrogenic and stem cell associated markers in co-culture 
groups of ADSCs:chondrocytes (a) Chondrogenic gene expression in co-culture groups of ADSCs: chondrocytes (1:1, 1:2, 2:1) 
compared with control (chondrocytes) for Collagen Type II and ACP (b) Stem cell associated gene (Nanog, Oct-4 and FGF-4) 
expression in co-culture groups of ADSCs: chondrocytes (1:1, 1:2, 2:1) compared with control (ADSCs) (Result are presented as 
mean ± standard deviation with n = 3. *denotes significant difference between 2:1 group, 1:1 and 1:2 group (p<0.05)
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expression might hinder the chondrogenesis of ADSCs in 
co-culture system. 
CONCLUSION
Our data suggested that chondrogenesis of ADSCs by co-
culture with chondrocytes in low serum is an appropriate 
strategy to provide chondrogenic cells for treating 
cartilage lesion in the clinical setting. This in view with 
the cell proliferation ability of the co-culture cells, the 
chondrogenic differentiation evidences, serum low 
dependency as well as animal serum substitution with an 
autologous patient’s serum. 
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